Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.28 -0.57 (-1.91%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) FCF Margin (2021 - 2024)

Updated

Amylyx Pharmaceuticals' FCF Margin was -192.00% in FY2024, down 194.80 percentage points from 2.80% in FY2023.

Analysis

Amylyx Pharmaceuticals (AMLX) FCF Margin (2021 - 2024) Analysis & Trends

From FY2021 onward, Amylyx Pharmaceuticals has reported FCF Margin for 4 years.

  • FCF Margin shows a three-year change of +26177.13 percentage points (FY2021 to FY2024).
  • Annual FCF Margin has moved between -26369.12% (FY2021) and 2.80% (FY2023) over five years.
  • Per Business Quant data, FCF Margin in earlier years was 2.80% in FY2023 (+823.30 pp), -820.50% in FY2022 (+25548.62 pp) and -26369.12% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Amylyx Pharmaceuticals 3.32 Bn 3.32 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -9,988.22%
Jun 30, 2024 -6,517.01%
Mar 31, 2024 -0.63%
Dec 31, 2023 12.17%
Sep 30, 2023 -5.38%
Jun 30, 2023 8.48%
Mar 31, 2023 -7.45%
Dec 31, 2022 -229.92%
Sep 30, 2022 -12,619.42%
Sep 30, 2021 -7,374.74%
API Access

Amylyx Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=AMLX&period=max&api_key=YOUR_API_KEY